Splice-Switching Antisense Oligonucleotides for Treating NLRP3-mediated Inflammatory Disease

Technology number: 2024-540

Ultrasound Assisted Gene Therapy

Technology number: 2023-335

Reprogramming Photoreceptor Metabolism to Enhance Survival and Prevent Vision Loss

Technology number: 7634

Design and Synthesis of Novel Retinoids

Technology number: 7453

Methods and Compositions for the Prevention of Cardiomyopathy and Muscle Injury in Muscular Dystrophy

Technology number: 3015

Bioinspired Nanotherapeutics for Managing Periapical Bone Inflammation

TECHNOLOGY NUMBER: 2024-524

Soluble Urokinase Plasminogen Activator Receptor (SuPAR) as a Therapeutic Target for Prevention and Treatment of Atherosclerosis

TECHNOLOGY NUMBER: 2021-428

Phosphatidylinositide 3-kinase Inhibitor Combined with Alpha-PD-1 Achieve Complete Remission in Metastatic Cancer

TECHNOLOGY NUMBER: 2021-366

Bile Salt and Corticosteroid Microparticles for Controlled Release Drug Delivery Applications

TECHNOLOGY NUMBER: 2021-314

Pharmacologic Activation of Autophagy without Direct mTOR Inhibition; a Therapeutic Strategy to Treat Dry Macular Degeneration

TECHNOLOGY NUMBER: 2020-502

Biodegradable protein based Nanoparticles for drug delivery

TECHNOLOGY NUMBER: 2020-143

High Density Electrophysiological Predicts Span of Therapeutic Tissue Activation Volumes in Subthalamic Deep Brain Stimulation …

TECHNOLOGY NUMBER: 2019-221

Chimeric Antigen Receptor Comprising CD123 Binding Domain and IL-7 Intracellular Signaling Domain for combination T Cell Therapy

TECHNOLOGY NUMBER: 2018-238

Hydrogel Guidance Tubes for Aligned Tissue Regeneration

TECHNOLOGY NUMBER: 7763

Use of 4-PBA for the Prevention and Treatment of Vascular Lesions in CM-AVM

TECHNOLOGY NUMBER: 2020-058

Tofacitinib for Treatment of Amyotrophic Lateral Sclerosis

TECHNOLOGY NUMBER: 2019-053

Use of Retinoids in Congenital Erythropoietic Porphyria

TECHNOLOGY NUMBER: 2022-276

Therapeutic Use of Carbamoyl Phosphate Synthatase-1

TECHNOLOGY NUMBER: 2019-076

Methods for the Treatment of Nicotine Dependence

TECHNOLOGY NUMBER: 2020-397

Pharmacotherapies for COVID-19

TECHNOLOGY NUMBER: 2020-487

Lactoferrin Inhibition of SARS-CoV-2 Viral Entry and Immunomodulatory Suppression of IL-6

TECHNOLOGY NUMBER: 2020-433

Selective Kinase Degraders (PROTACs) for Oncology

TECHNOLOGY NUMBER: 2022-262

Meta Anilide Inhibitors of MRTF

TECHNOLOGY NUMBER: 2021-316

HDAC6 Inhibitors to Treat Diabetes

TECHNOLOGY NUMBER: 2021-217

Composition for Monomer Ash1L Inhibitors and Method of Use Thereof

TECHNOLOGY NUMBER: 2019-153

High-Throughput Screening Method for Identifying Monoclonal Antibodies with Drug-Like Colloidal and Viscoelastic Properties

TECHNOLOGY NUMBER: 2019-346

Graves Eye Disease New Treatment

TECHNOLOGY NUMBER: 2018-321

Polygenic Markers of Hepatic Steatosis and Cirrhosis

TECHNOLOGY NUMBER: 2021-461

Modulating the Gut Microbiome to Treat Disease

TECHNOLOGY NUMBER: 2022-186

PRC1 Inhibitors

TECHNOLOGY NUMBER: 2018-372

Novel Small Molecules and Their Use as MALT1 Inhibitors

TECHNOLOGY NUMBER: 2021-126

Novel Structure-Based Rifamycins for Drug-Resistant TB and HIV Co-Infection

TECHNOLOGY NUMBER: 2021-114

ML355-sHDL as a New Delivery Mechanism for Antiplatelet Therapy Targeting 12-Lipoxygenase

TECHNOLOGY NUMBER: 2021-132

The Method to Give Bacteria Probiotic Features by Genetic Engineering

TECHNOLOGY NUMBER: 2021-103

Carbon Nanotubules for Delivery of the Ocular Drugs

TECHNOLOGY NUMBER: 2019-427

Photomediated Ultrasound Therapy Method and Apparatus

TECHNOLOGY NUMBER: 7785

GRP78 Inhibitors and Degraders for the Treatment of Cancer, Viral Infection, and Inflammatory Diseases

TECHNOLOGY NUMBER: 2021-276

2-Hydroxybenzoic Acid Derivatives as Inhibitors and Degraders of Sirtuins

TECHNOLOGY NUMBER: 2022-340

Modulation of Pyruvate Kinase M2 as a Therapeutic Strategy for Proliferative Vitreoretinopathy

TECHNOLOGY NUMBER: 2022-202

BanLec-CAR T Cells for Cancer Therapy

TECHNOLOGY NUMBER: 2019-123

Compositions and Methods for Treating Adrenocortical Carcinoma and Excess Steroid Production

TECHNOLOGY NUMBER: 7401

Small-Molecule Inhibitors of DCN1

TECHNOLOGY NUMBER: 7301

Covalent Small-Molecule Inhibitors of DCN1 Protein

TECHNOLOGY NUMBER: 7456

ARlnc1 in Prostate Cancer Progression

TECHNOLOGY NUMBER: 7386

Lipids for Nucleic Acid Based Vaccines

TECHNOLOGY NUMBER: 2022-117

Dual-Function Lipidated NCEs

TECHNOLOGY NUMBER: 2022-116

Chlorophenyl Inhibitors of Glucosylceramide Synthase

TECHNOLOGY NUMBER: 2019-311

Pyridine Inhibitors of Glucosylceramide Synthase

TECHNOLOGY NUMBER: 2019-268

Synthetic High Density Lipoprotein for Treatment of Infections Complications

TECHNOLOGY NUMBER: 2020-434

A Small Molecular Compound for Arthritis and Bone Erosion Treatment

TECHNOLOGY NUMBER: 7656

New Oral Drug Strategy for Targeting Pancreas

TECHNOLOGY NUMBER: 2021-411

Gastrointestinal (GI) Locally-Activating JAK Inhibitor for Treatment of Ulcerative Colitis

TECHNOLOGY NUMBER: 2022-281

Targeting Oncogenic Transcriptional Programs Through Tissue Specificity

TECHNOLOGY NUMBER: 2021-208

Nanoemulsion Vaccine Induces Cross-Protection to Suppress Reactivity to Multiple Food Allergens

TECHNOLOGY NUMBER: 2021-194

BpV(pic) and Hair Growth

TECHNOLOGY NUMBER: 2021-308

IgA Induced Mucosal Immune Tolerance

TECHNOLOGY NUMBER: 2021-134

Novel Drug Formulation

TECHNOLOGY NUMBER: 2019-436

Role of Nanoemulsion Vaccine in Chronic Cockroach Allergic Asthma

TECHNOLOGY NUMBER: 2019-481

Sting Agonist, Nanoformulations, and their uses For Treatment of Cancer, Viral Infection, and Bacterial Infection

TECHNOLOGY NUMBER: 2022-078

SGLT Inhibitor Drug for Treating Liver Diseases

TECHNOLOGY NUMBER: 2021-312

Combined Agonist Adjuvants for Vaccines

TECHNOLOGY NUMBE: 2021-322

Microbial Metabolites for Improving Cancer Immunotherapy

TECHNOLOGY NUMBER: 2021-483

Small Molecule Activation of Lysosomal TRP Channels Ameliorates Duchenne Muscular Dystrophy in Mouse Models

TECHNOLOGY NUMBER: 2019-270

PKC Inhibition to Allow Extended tPA Treatment for Stroke

TECHNOLOGY NUMBER: 7702

Updated Non-Invasive Cervical Cerclage

TECHNOLOGY NUMBER: 2021-392

Cancer Stem Cell Vaccination and Treatment

TECHNOLOGY NUMBER: 5486

Phase Correction for Single Pixel Camera in a Lissajous Pattern

TECHNOLOGY NUMBER: 2018-422

A Concentrated Form of Valproate to be Delivered via Bone for the Treatment of Hemorrhagic Shock

TECHNOLOGY NUMBER: 2019-471

Small Molecule Positive Modulators of Ligand-Induced Ret Signaling

Development of a Therapeutic Against Flavivirus NS1 Protein as a Treatment for Flavivirus Infection

TECHNOLOGY NUMBER: 2020-429

Novel Particles as an Acute Lung Injury Therapeutic via Rapid Blocking of Neutrophil Migration in the Lungs

TECHNOLOGY NUMBER: 2019-409

Development of Novel Pyruvate Kinase Muscle Isoform 2 (PKM2) Activators for Photoreceptor Neuroprotection

TECHNOLOGY NUMBER: 2020-183

Mitochondrial Targeting Compounds for the Treatment of Associated Diseases

TECHNOLOGY NUMBER: 2020-134

Methods for Establishing Drug Supersaturation from a Porous Host

TECHNOLOGY NUMBER: 2019-069

Ear Implant for Reconstruction

TECHNOLOGY NUMBER: 7095